Pomen sledljivosti krvnih pripravkov

Miložič, Luka

| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

First page > Show document

Show document

Title:	Pomen sledljivosti krvnih pripravkov
Authors:	ID Miložič, Luka (Author) ID Lorber, Mateja (Mentor) More about this mentor... ID Lokar, Lidija (Comentor)
Files:	VS_Milozic_Luka_2011.pdf (1,80 MB) MD5: C52193B9FA9618816A0B181BD1F25310 PID: 20.500.12556/dkum/3bcfec41-7741-46b1-8311-28d035fc26a4
Language:	Slovenian
Work type:	Undergraduate thesis
Organization:	FZV - Faculty of Health Sciences
Abstract:	V diplomskem delu je predstavljena sledljivost krvnih pripravkov, ki zajema vsa področja transfuzijske verige od »vene do vene«. Prav tako je predstavljena vloga medicinske sestre pri sledljivosti krvnih pripravkov, in sicer pred, med in po transfuziji. Osebje, ki sodeluje v transfuzijski verigi, mora biti ustrezno usposobljeno, poznati mora zakone in priporočila, po katerih mora upravljati svojo nalogo. S pravilnim delovanjem lahko Center za transfuzijsko medicino ugotovi, kje v transfuzijski verigi je prišlo do napake. To jim omogoča vpeljan sistem hemovigilance, katerega naloge niso le zbiranje podatkov o sledljivosti, temveč tudi izboljšanje delovanja v celotni transfuzijski verigi. Namen raziskave je bil ugotoviti ali je poročanje oddelkov Centru za transfuzijsko medicino Univerzitetnega kliničnega centra Maribor dosledno z zakoni. Osredotočili smo se na vse oddelke Klinike za kirurgijo Univerzitetnega kliničnega centra Maribor, ki so največji porabniki krvnih komponent. Pri tem smo uporabljali izdajnice in informacijski sistem DATEC. Rezultati raziskave so pokazali, da oddelki Klinike za kirurgijo ne poročajo dosledno z zakoni in da veliko izdajnic ni vrnjenih Centru za transfuzijsko medicino. Od vsega 13.175 prejetih krvnih komponent v letu 2010, so oddelki poročali o 38 % (5049) transfundiranih krvnih komponentah. Za ostalih 62 % (8162) enot komponent niso posredovali informacije o uporabi. Poročali so o vsega skupaj 19 neželenih reakcijah, med katerimi so bile najpogostejše alergične in fibrilne nehemolitične reakcije. Poročali so tudi o 7 skorajšnjih neželenih dogodkih. Zaradi slabega poročanja Center za transfuzijsko medicino težko ugotovi kaj se dogaja s krvjo, katera komponenta je bila transfundirana oziroma ni bila. Potrebno bi bilo izboljšati poročanje oddelkov z dodatnim informiranjem vsega zdravstvenega osebja, katero sodeluje v transfuzijski verigi. Dosledno poročanje bo pripomoglo k vedno bolj varni transfuziji krvi.
Keywords:	sledljivost, krvni pripravki, hemovogilanca, neželeni učinki transfuzije, varnost in kakovost transfuzije, zakonodaja
Place of publishing:	Maribor
Publisher:	[L. Miložič]
Year of publishing:	2011
PID:	20.500.12556/DKUM-19758
UDC:	615.38
COBISS.SI-ID:	1730980
NUK URN:	URN:SI:UM:DK:FU0E2SLS
Publication date in DKUM:	07.12.2011
Views:	2737
Downloads:	333
Metadata:
Categories:	FZV
:	Copy citation

Average score:	(0 votes)
Your score:	Voting is allowed only for logged in users.
Share:

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Secondary language

Language:	English
Title:	The importance of traceability of blood products
Abstract:	The diploma work presents the tracking of blood preparations and it contains all areas of the transfusion chain, from “vein to vein”. Also, the role of a nurse in tracking of blood preparations is presented before, during and after the transfusion. The personnel cooperating in the transfusion chain has to be properly qualified, has to know the laws and recommendations that guide their tasks. With the accurate procedure the Centre for Transfusion Medicine can define where in the transfusion chain a mistake arose. That is made possible for through the introduced system of hemovigilance, which tasks is not only collecting the data of the tracking but also the improvement of the procedure in the entire transfusion chain. The objective of the research was to find out if the reporting from the departments to the Centre for Transfusion Medicine of the University Medical Centre Maribor was consistent with the laws. Our main focus was on all the departments of the surgical clinic in the University Medical Centre Maribor who are the biggest consumers of blood components. In the research we relied on blood issue forms and the information system DATEC. The results of the research showed the surgical clinic does not report consistently with the law and that many of the blood issue forms were not returned to the Centre for Transfusion Medicine. Out of all 13,175 units of received blood components in the year 2010 the departments reported about 38 percent (5,049 units) transfused blood components. For the other 62 percent (8,162 units) of blood components there have not been any reports or information on the usage. They reported about nineteen unwanted reactions. Among those the most common were allergic and nonhemolytic febrile reactions. They also reported seven “near-miss” events, in which improper transfusion was prevented right before the administration. Because of the poor reports the Centre for Transfusion Medicine finds it difficult to establish what is happening with the blood whose component were or were not transfused. It would be beneficial to improve the reports from the departments by additionally informing the medical personnel, who are involved in the transfusion chain, about the upsides of hemovigilance. Consistent reports would aid to safer blood transfusions.
Keywords:	tracking, blood preparation, hemovigilance, unwanted reactions of the transfusion, safety and quality of the transfusion, legislation

Comments

Leave comment

You must log in to leave a comment.

Comments (0)

0 - 0 / 0

There are no comments!

Back